Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: Insights from genetically modified mice

Journal of Physiology

Volumn 590, Issue 16, 2012, Pages 4079-4091

  Chen, Ruo Li ^a   Nagel, Simon ^a,b   Papadakis, Michalis ^a   Bishop, Tammie ^a   Pollard, Patrick ^a   Ratcliffe, Peter J ^a   Pugh, Christopher W ^a   Buchan, Alastair M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOENZYME; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYL 4 HYDROXYLASE 1; PROLYL 4 HYDROXYLASE 2; PROLYL 4 HYDROXYLASE 3; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BEHAVIOR CHANGE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN INFARCTION SIZE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LASER DOPPLER FLOWMETRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; TRANSGENIC ANIMAL; TRANSIENT ISCHEMIC ATTACK; WILD TYPE;

ANIMALS; BODY TEMPERATURE REGULATION; BODY WEIGHT; BRAIN ISCHEMIA; CEREBRAL ARTERIES; CEREBRAL CORTEX; GENE EXPRESSION REGULATION; GENOTYPE; MALE; MICE; MICE, KNOCKOUT; PROCOLLAGEN-PROLINE DIOXYGENASE; PROTEIN ISOFORMS;

EID: 84865627686     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.232884     Document Type: Article

References (49)

1. Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, Grubb RL, Higashida R, Kidwell C, Kwiatkowski TG, Marler JR & Hademenos GJ (2003). Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association. Stroke 34, 1056-1083.
2. Appelhoff RJ, Tian YM, Raval RR, Turley H, Harris AL, Pugh CW, Ratcliffe PJ & Gleadle JM (2004). Differential function of the Prolyl Hydroxylases PHD1, PHD2 and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 279, 38458-38465.
3. Aragonés J, Schneider M, Van Geyte K, Fraisl P, Dresselaers T, Mazzone M, Dirkx R, Zacchigna S, Lemieux H, Jeoung NH, Lambrechts D, Bishop T, Lafuste P, Diez-Juan A, Harten SK, Van Noten P, De Bock K, Willam C, Tjwa M, Grosfeld A, Navet R, Moons L, Vandendriessche T, Deroose C, Wijeyekoon B, Nuyts J, Jordan B, Silasi-Mansat R, Lupu F, Dewerchin M, Pugh C, Salmon P, Mortelmans L, Gallez B, Gorus F, Buyse J, Sluse F, Harris RA, Gnaiger E, Hespel P, Van Hecke P, Schuit F, Van Veldhoven P, Ratcliffe P, Baes M, Maxwell P & Carmeliet P (2008). Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 40, 170-180.
4. Baranova O, Miranda LF, Pichiule P, Dragatsis I, Johnson RS & Chavez JC (2007). Neuron-specific inactivation of the hypoxia inducible factor 1α increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci 27, 6320-6332.
5. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL & Bartkowski H (1986). Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17, 472-476.
6. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G & Smith K (2002). Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346, 557-563.
7. Berra E, Benizri E, Ginouvès A, Volmat V, Roux D & Pouysségur J (2003). HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J 22, 4082-4090.
8. Bishop T, Gallagher D, Pascual A, Lygate CA, de Bono JP, Nicholls LG, Ortega-Saenz P, Oster H, Wijeyekoon B, Sutherland AI, Grosfeld A, Aragones J, Schneider M, van Geyte K, Teixeira D, Diez-Juan A, Lopez-Barneo J, Channon KM, Maxwell PH, Pugh CW, Davies AM, Carmeliet P & Ratcliffe PJ (2008). Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice. Mol Cell Biol 28, 3386-3400.
9. Cabanas JG, Brice JH, De Maio VJ, Myers B & Hinchey PR (2011). Field-induced therapeutic hypothermia for neuroprotection after out-of hospital cardiac arrest: a systematic review of the literature. J Emerg Med 40, 400-409.
10. Chan DA, Kawahara TL, Sutphin PD, Chang HY, Chi JT & Giaccia AJ (2009). Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment. Cancer Cell 15, 527-538.
11. Chen C, Hu Q, Yan J, Yang X, Shi X, Lei J, Chen L, Huang H, Han J, Zhang JH & Zhou C (2009). Early inhibition of HIF-1α with small interfering RNA reduces ischemic-reperfused brain injury in rats. Neurobiol Dis 33, 509-517.
12. Chen RL, Balami J, Esiri M, Chen LH & Buchan AM (2010). Stroke in ageing: an overview of evidence. Nat Rev Neurology 6, 256-265.
13. Connolly ES, Winfree CJ, Stern DM, Solomon RA & Pinsky DJ (1996). Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia. Neurosurgery 38, 523-532.
14. Demidenko ZN & Blagosklonny MV (2011). The purpose of the HIF-1/PHD feedback loop: to limit mTOR-induced HIF-1α. Cell Cycle 10, 1557-1562.
15. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ & Ratcliffe PJ (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
16. Fu J, Menzies K, Freeman RS & Taubman MB (2007). EGLN3 prolyl hydroxylase regulates skeletal muscle differentiation and myogenin protein stability. J Biol Chem 282, 12410-12418.
17. Fujii M, Hara H, Meng W, Vonsattel JP, Huang Z & Moskowitz MA (1997). Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57black/6 mice. Stroke 28, 1805-1810.
18. Geiger K, Leiherer A, Muendlein A, Stark N, Geller-Rhomberg S, Saely CH, Wabitsch M, Fraunberger P & Drexel H (2011). Identification of hypoxia-induced genes in human SGBS adipocytes by microarray analysis. PLoS One 6, e26465.
19. Harten SK, Ashcroft M & Maxwell PH (2010). Prolyl hydroxylase domain inhibitors: a route to HIF activation and neuroprotection. Antioxid Redox Signal 12, 459-480.
20. Horak P, Crawford AR, Vadysirisack DD, Nash ZM, DeYoung MP, Sgroi D & Ellisen LW (2010). Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc Natl Acad Sci U S A 107, 4675-4680.
21. Huang M, Chan DA, Jia F, Xie X, Li Z, Hoyt G, Robbins RC, Chen X, Giaccia AJ & Wu JC (2008). Short hairpin RNA interference therapy for ischemic heart disease. Circulation 118(14 Suppl), S226-S233.
22. Hyvärinen J, Hassinen IE, Sormunen R, Mäki JM, Kivirikko KI, Koivunen P & Myllyharju J (2010). Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury. J Biol Chem 285, 13646-13657.
23. Kaelin WG Jr & Ratcliffe PJ (2008). Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 30, 393-402.
24. Kelly TJ, Souza AL, Clish CB & Puigserver P (2011). A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1α stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like. Mol Cell Biol 31, 2696-2706.
25. Köditz J, Nesper J, Wottawa M, Stiehl DP, Camenisch G, Franke C, Myllyharju J, Wenger RH & Katschinski DM (2007). Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor. Blood 110, 3610-3617.
26. Loenarz C & Schofield CJ (2008). Expanding chemical biology of 2-oxoglutarate oxygenases. Nat Chem Biol 4, 152-156.
27. Loinard C, Ginouvès A, Vilar J, Cochain C, Zouggari Y, Recalde A, Duriez M, Lévy BI, Pouysségur J, Berra E & Silvestre JS (2009). Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization. Circulation 120, 50-59.
28. Mazzone M, Dettori D, Leite de Oliveira R, Loges S, Schmidt T, Jonckx B, Tian YM, Lanahan AA, Pollard P, Ruiz de Almodovar C, De Smet F, Vinckier S, Aragonés J, Debackere K, Luttun A, Wyns S, Jordan B, Pisacane A, Gallez B, Lampugnani MG, Dejana E, Simons M, Ratcliffe P, Maxwell P & Carmeliet P (2009). Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136, 839-851.
29. McColl BW, Carswell HV, McCulloch J & Horsburgh K (2004). Extension of cerebral hypoperfusion and ischaemic pathology beyond MCA territory after intraluminal filament occlusion in C57Bl/6J mice. Brain Res 997, 15-23.
30. Metzen E, Berchner-Pfannschmidt U, Stengel P, Marxsen JH, Stolze I, Klinger M, Huang WQ, Wotzlaw C, Hellwig-Bürgel T, Jelkmann W, Acker H & Fandrey J (2003). Intracellular localisation of human HIF-1α hydroxylases: implications for oxygen sensing. J Cell Sci 116, 1319-1326.
31. Milkiewicz M, Pugh CW & Egginton S (2004). Inhibition of endogenous HIF inactivation induces angiogenesis in ischaemic skeletal muscles of mice. J Physiol 560, 21-26.
32. Minamishima YA, Moslehi J, Bardeesy N, Cullen D, Bronson RT, Kaelin WG Jr (2008). Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood 111, 3236-3244.
33. Nagel S, Talbot NP, Mecinović J, Smith TG, Buchan AM & Schofield CJ (2010). Therapeutic manipulation of the HIF hydroxylases. Antioxid Redox Signal 12, 481-501.
34. Nagel S, Papadakis M, Chen R, Hoyte LC, Brooks KJ, Gallichan D, Sibson NR, Pugh C & Buchan AM (2011). Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 31, 132-143.
35. Nangaku M, Izuhara Y, Takizawa S, Yamashita T, Fujii-Kuriyama Y, Ohneda O, Yamamoto M, van Ypersele de Strihou C, Hirayama N & Miyata T (2007). A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia. Arterioscler Thromb Vasc Biol 27, 2548-2554.
36. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH & Howells DW (2006). 1, 026 experimental treatments in acute stroke. Ann Neurol 59, 467-477.
37. Pugh CW & Ratcliffe PJ (2003). Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9, 677-684.
38. Puchowicz MA, Zechel JL, Valerio J, Emancipator DS, Xu K, Pundik S, LaManna JC & Lust WD (2008). Neuroprotection in diet-induced ketotic rat brain after focal ischemia. J Cereb Blood Flow Metab 28, 1907-1916.
39. Siddiq A, Ayoub IA, Chavez JC, Aminova L, Shah S, LaManna JC, Patton SM, Connor JR, Cherny RA, Volitakis I, Bush AI, Langsetmo I, Seeley T, Gunzler V & Ratan RR (2005). Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J Biol Chem 280, 41732-41743.
40. Siddiq A, Aminova LR, Troy CM, Suh K, Messer Z, Semenza GL & Ratan RR (2009). Selective inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF- and CREB-independent pathways. J Neurosci 29, 8828-8838.
41. Sutherland BA, Papadakis M, Chen RL & Buchan AM (2011). Cerebral blood flow alteration in neuroprotection following cerebral ischaemia. J Physiol 589, 4105-4114.
42. Takeda K, Ho VC, Takeda H, Duan LJ, Nagy A & Fong GH (2006). Placental but not heart defects are associated with elevated hypoxia-inducible factor α levels in mice lacking prolyl hydroxylase domain protein 2. Mol Cell Biol 26, 8336-8346.
43. Takeda K, Aguila HL, Parikh NS, Li X, Lamothe K, Duan LJ, Takeda H, Lee FS & Fong GH (2008). Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood 111, 3229-3235.
44. Takeda Y, Costa S, Delamarre E, Roncal C, Leite de Oliveira R, Squadrito ML, Finisguerra V, Deschoemaeker S, Bruyère F, Wenes M, Hamm A, Serneels J, Magat J, Bhattacharyya T, Anisimov A, Jordan BF, Alitalo K, Maxwell P, Gallez B, Zhuang ZW, Saito Y, Simons M, De Palma M & Mazzone M (2011). Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 479, 122-126.
45. The Hypothermia after Cardiac Arrest Study Group (2002). Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346, 549-556.
46. Won SJ, Kim DY & Gwag BJ (2002). Cellular and molecular pathways of ischemic neuronal death. J Biochem Mol Biol 35, 67-86.
47. 2-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL. Sci Signal 2, ra33.
48. Yuan J (2009). Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke. Apoptosis 14, 469-477.
49. Zhang H, Prabhakar P, Sealock R & Faber JE (2010). Wide genetic variation in the native pial collateral circulation is a major determinant of variation in severity of stroke. J Cereb Blood Flow Metab 30, 923-934.